BSP Pharmaceuticals S.r.l. was pleased to announce its presence to the World ADC Summit 2014 in San Diego. The annual summit - is the main scientific event for the research, development and production of anticancer drugs ADC (Antibody Drug Conjugated). This summit was open to the major research centers and pharmaceutical companies. It was the industry’s longest standing and most comprehensive antibody-drug conjugated annual conference. The value that this event provides was the power of insight and the connections to develop more clinically impactful ADCs. During the first day of this summit, Maria Elena Guadagno, our Business Director held the speech: “Conjugation & Fill-Finish: A New Concept Applied to the Supply Chain of ADCs – from Earlier Conjugation Development to GMP Commercial Manufacturing”
